Publications

Detailed Information

Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1

DC Field Value Language
dc.contributor.authorLee, Ha-reum-
dc.contributor.authorYoon, Sun Young-
dc.contributor.authorKang, Ho-Bum-
dc.contributor.authorPark, Sunyoung-
dc.contributor.authorCho, Young Hoon-
dc.contributor.authorKim, Chul-woo-
dc.contributor.authorLee, Wang Jae-
dc.contributor.authorPark, Hyunjeong-
dc.contributor.authorCho, Daeho-
dc.contributor.authorBang, Sa Ik-
dc.contributor.authorCho, Byung Joo-
dc.contributor.authorKim, Seonghan-
dc.contributor.authorKim, Kyung-Eun-
dc.date.accessioned2012-07-09T08:27:28Z-
dc.date.available2012-07-09T08:27:28Z-
dc.date.issued2009-03-24-
dc.identifier.citationIMMUNOLOGY LETTERS; Vol.123(1); 72-76ko_KR
dc.identifier.issn0165-2478-
dc.identifier.urihttps://hdl.handle.net/10371/78667-
dc.description.abstractThymosin beta 4 (T beta 4), which is the major G-actin sequestering protein, has been shown to have ubiquitous distribution and multiple biological activities. However, T beta 4`s functions in relation to natural killer (NK) cells are still unknown. In this study, we show that synthetic T beta 4 peptide increases NK cell cytotoxicity mediated by intercellular adhesion molecule-1 (ICAM-1) through the secretion of cytolytic granules to target cells. This suggests that T beta 4 is a key activator of NK cell cytotoxicity.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectThymosin beta 4ko_KR
dc.subjectNK cell cytotoxicityko_KR
dc.subjectICAM-1ko_KR
dc.titleThymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1ko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이하름-
dc.contributor.AlternativeAuthor윤선영-
dc.contributor.AlternativeAuthor강호범-
dc.contributor.AlternativeAuthor박선영-
dc.contributor.AlternativeAuthor김경은-
dc.contributor.AlternativeAuthor조영훈-
dc.contributor.AlternativeAuthor김성한-
dc.contributor.AlternativeAuthor김철우-
dc.contributor.AlternativeAuthor조병주-
dc.contributor.AlternativeAuthor이왕재-
dc.contributor.AlternativeAuthor방사익-
dc.contributor.AlternativeAuthor박현정-
dc.contributor.AlternativeAuthor조대호-
dc.identifier.doi10.1016/j.imlet.2009.02.008-
dc.citation.journaltitleIMMUNOLOGY LETTERS-
dc.description.citedreferenceYang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y-
dc.description.citedreferenceVivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582-
dc.description.citedreferenceTerme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580-
dc.description.citedreferenceLanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276-
dc.description.citedreferenceBednarek R, 2008, J BIOL CHEM, V283, P1534, DOI 10.1074/jbc.M707539200-
dc.description.citedreferenceYoon SR, 2007, MOL CELLS, V24, P1-
dc.description.citedreferenceLjunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073-
dc.description.citedreferenceFujii H, 2007, BLOOD, V109, P2008, DOI 10.1182/blood-2006-02-002055-
dc.description.citedreferenceSmart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383-
dc.description.citedreferenceHannappel E, 2007, ANN NY ACAD SCI, V1112, P21, DOI 10.1196/annals.1415.018-
dc.description.citedreferenceKannana L, 2007, ANN NY ACAD SCI, V1112, P425, DOI 10.1196/annals.1415.028-
dc.description.citedreferenceCierniewski CS, 2007, ANN NY ACAD SCI, V1112, P123, DOI 10.1196/annals.1415.019-
dc.description.citedreferenceSun HQ, 2007, ANN NY ACAD SCI, V1112, P45, DOI 10.1196/annals.1415.021-
dc.description.citedreferenceMarcenaro E, 2006, TRANSPL IMMUNOL, V17, P16, DOI 10.1016/j.trim.2006.09.019-
dc.description.citedreferenceBryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351-
dc.description.citedreferenceBryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143-
dc.description.citedreferenceGoldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004-
dc.description.citedreferenceNakachi K, 2004, CANCER SCI, V95, P921-
dc.description.citedreferenceAlter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008-
dc.description.citedreferenceBarber DF, 2004, J IMMUNOL, V173, P3653-
dc.description.citedreferenceAl-Nedawi KNI, 2004, BLOOD, V103, P1319, DOI 10.1182/blood-2003-04-1015-
dc.description.citedreferenceKLINMAN DM, 2004, NAT REV IMMUNOL, V4, P249-
dc.description.citedreferenceOrange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100-
dc.description.citedreferenceCha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100-
dc.description.citedreferenceWu J, 2003, ADV CANCER RES, V90, P127-
dc.description.citedreferenceHannappel E, 2003, VITAM HORM, V66, P257-
dc.description.citedreferenceVyas YM, 2002, IMMUNOL REV, V189, P161-
dc.description.citedreferenceColombo MP, 2002, CYTOKINE GROWTH F R, V13, P155-
dc.description.citedreferenceRobertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173-
dc.description.citedreferenceSosne G, 2002, CURR EYE RES, V24, P268-
dc.description.citedreferenceBalkow S, 2001, J VIROL, V75, P8781-
dc.description.citedreferenceHuff T, 2001, INT J BIOCHEM CELL B, V33, P205-
dc.description.citedreferenceImai K, 2000, LANCET, V356, P1795-
dc.description.citedreferencevan Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542-
dc.description.citedreferenceCho DH, 2000, CELL IMMUNOL, V199, P1-
dc.description.citedreferenceMalinda KM, 1999, J INVEST DERMATOL, V113, P364-
dc.description.citedreferenceSantelli G, 1999, AM J PATHOL, V155, P799-
dc.description.citedreferenceBauer S, 1999, SCIENCE, V285, P727-
dc.description.citedreferenceBiron CA, 1999, ANNU REV IMMUNOL, V17, P189-
dc.description.citedreferenceMalinda KM, 1997, FASEB J, V11, P474-
dc.description.citedreferenceNAGATA S, 1995, SCIENCE, V267, P1449-
dc.description.citedreferenceKAGI D, 1994, NATURE, V369, P31-
dc.description.citedreferenceSAFER D, 1991, J BIOL CHEM, V266, P4029-
dc.description.citedreferenceROBERTSON MJ, 1990, J IMMUNOL, V145, P3194-
dc.description.citedreferenceRUDIN CM, 1990, J IMMUNOL, V144, P4857-
dc.description.citedreferenceTIMONEN T, 1988, J IMMUNOL, V141, P1041-
dc.description.citedreferenceWELLER FE, 1988, J BIOL RESP MODIF, V7, P91-
dc.description.citedreferenceETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784-
dc.description.citedreferenceETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623-
dc.description.citedreferenceLOW TLK, 1982, J BIOL CHEM, V257, P1000-
dc.description.citedreferenceGOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010-
dc.description.tc3-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share